Items where Author is "Vogler, Sabine"

Article

Knoll, Verena; Steigenberger, Caroline; Fischer, Stefan; Vogler, Sabine; Tamussino, Karl; Deters, M. (2026): Made in Europe - assessing the feasibility of reshoring active pharmaceutical ingredient production to Europe. Health Policy, 166. p. 105566

Zoltán, Kaló; Kruja, Krista; Vogler, Sabine; Docteur, Elizabeth (2025): Collective international action to increase access to costly drugs: pooled procurement and equity based tiered pricing. BMJ (391). e084839

Vogler, Sabine; Knoll, Verena; Salcher-Konrad, Maximilian (2025): Community pharmacy services in the late COVID-19 period: What has driven change? Research in Social an Administrative Pharmacy, 21 (7). pp. 505-516

Sharma, Tarang; Kruja, Krista; Årdal, Christine; Lopert, Ruth; Mestre-Ferrandiz, Jorge; Boselli, Simone; Vogler, Sabine (2025): Managing costly new drugs to support equitable access: international collaboration and patient engagement to assess value, and managed entry agreements. BMJ (391). e086174

Vogler, Sabine; Zimmermann, Nina; Haasis, Manuel Alexander; Gombocz, Margit; Knoll, Verena (2024): Approaching two decades of information sharing between competent authorities: Experience from the Pharmaceutical Pricing and Reimbursement Information (PPRI) network. Journal of Pharmaceutical Policy and Practice. Abstracts from the 5th PPRI conference 2024: ensuring access to affordable medicines through innovative policies, Vienna, Austria, 25–26 April 2024, 17 (1).

Vogler, Sabine; Salcher-Konrad, Maximilian; Knoll, Verena (2024): Community pharmacy in Austria, England, Estonia and Portugal: Has the COVID-19 pandemic changed the range of pharmacy services offered. Journal of Pharmaceutical Policy and Practice. Abstracts from the 5th PPRI conference 2024: ensuring access to affordable medicines through innovative policies, Vienna, Austria, 25–26 April 2024, 17 (1).

Schneider, Peter; Salcher-Konrad, Maximilian; Vogler, Sabine (2024): European comparison of prices for off-patent medicines – findings for 16 countries and implications for methodological choices. Journal of Pharmaceutical Policy and Practice. Abstracts from the 5th PPRI conference 2024: ensuring access to affordable medicines through innovative policies, Vienna, Austria, 25–26 April 2024, 17 (1).

Vogler, Sabine; Steigenberger, Caroline; Windisch, Friederike (2024): Improving antibiotic prescribing – Recommendations for funding and pricing policies to enhance use of point-of-care tests. Health Policy OPEN, 7. p. 100129 ISSN 0168-8510

Vogler, Sabine (2024): Increasing prices to ensure availability of medicines? Financial incentives implemented as shortage mitigation policy in PPRI member countries. Journal of Pharmaceutical Policy and Practice. Abstracts from the 5th PPRI conference 2024: ensuring access to affordable medicines through innovative policies, Vienna, Austria, 25–26 April 2024, 17 (1).

Vogler, Sabine; Zimmermann, Nina; Haasis, Manuel Alexander; Knoll, Verena; Espin Balbino, Jaime; Mantel-Teeuwisse, Aukje K. (2024): Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines. Journal of Pharmaceutical Policy and Practice, 17 (1). p. 2335492

Knoll, Verena; Steigenberger, Caroline; Fischer, Stefan; Vogler, Sabine (2024): Made in Europe - assessing the feasibility of reshoring active pharmaceutical ingredient (API) production to Europe. Journal of Pharmaceutical Policy and Practice. Abstracts from the 5th PPRI conference 2024: ensuring access to affordable medicines through innovative policies, Vienna, Austria, 25–26 April 2024, 17 (1).

Salcher-Konrad, Maximilian; Stefan, M; Knoll, Verena; Vogler, Sabine (2024): Pharmaceutical care in Austria: A survey on services provided by community pharmacies. Journal of Pharmaceutical Policy and Practice. Abstracts from the 5th PPRI conference 2024: ensuring access to affordable medicines through innovative policies, Vienna, Austria, 25–26 April 2024, 17 (1).

Panteli, Dimitra; Anderson, Michael; Fieldman, Thomas; Baraldi, Enrico; Tägdén, Thomas; Vogler, Sabine; Ardal, Christine; Mossialos, Elias (2024): Policy options for sustainable access to off-patent antibiotics in Europe. npj Antimocrob Resist, 2 (40).

Vogler, Sabine; Habimana, Katharina; Haasis, Manuel Alexander; Fischer, Stefan (2024): Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally. Appl Health Econ Health Policy, 22. pp. 629-652

Franzen, Nora; Vancoppenolle, Julie; Vogler, Sabine; Retel, Valesca; van Harten, Wim (2024): Savings and Transparency: Comparing Publicly Reported Data on Managed Entry Agreements in Europe. Journal of Pharmaceutical Policy and Practice. Abstracts from the 5th PPRI conference 2024: ensuring access to affordable medicines through innovative policies, Vienna, Austria, 25–26 April 2024, 17 (1).

Leopold, Christine; Vogler, Sabine; Suleman, Fatima; Wirtz, Veronika J. (2024): Strengthening primary health care through a stronger emphasis on patient and community centered medicines and pharmaceutical services. Journal of Pharmaceutical Policy and Practice. Abstracts from the 5th PPRI conference 2024: ensuring access to affordable medicines through innovative policies, Vienna, Austria, 25–26 April 2024, 17 (1).

Vogler, Sabine (2024): Tackling medicine shortages during and after the COVID-19 pandemic: Compilation of governmental policy measures and developments in 38 countries. Health Policy, 143 (May). p. 105030 ISSN 0168-8510

Vogler, Sabine; Salcher-Konrad, Maximilian; Habimana, Katharina (2024): Use of strategic approaches in public procurement of medicines: improving affordable patient access to medicines and protecting the environment in 32 European countries. Journal of Pharmaceutical Policy and Practice. Abstracts from the 5th PPRI conference 2024: ensuring access to affordable medicines through innovative policies, 17 (1).

Vogler, Sabine; Zimmermann, Nina; Knoll, Verena; Salcher-Konrad, Maximilian; Windisch, Friederike; Espin Balbino, Jaime; Mantel-Teeuwisse, Aukje; Panteli, Dimitra; Suleman, Fatima; Wirtz, Veronika J.; Babar, Zaheer-Ud-Din (2024): We need to be part of the solution’: lessons from the 2024 PPRI Conference on ensuring access to affordable medicines through innovative policies. Journal of Pharmaceutical Policy and Practice, 17 (1). p. 2442002 ISSN 2052-3211

Steigenberger, Caroline; Windisch, Friederike; Vogler, Sabine (2023): Barriers and Facilitators in Pricing and Funding Policies of European Countries That Impact the Use of Point-of-Care Diagnostics for Acute Respiratory Tract Infections in Outpatient Practices. Diagnostics, 13. p. 3596

Vogler, Sabine; Steigenberger, Caroline (2023): HPR146 Fit for Purpose Policy Recommendations Related to Funding, Pricing, and Procurement of Point-of-Care Tests Used in Patients With Respiratory Tract Infections. Value in Health, 26 (12). p. 279

Leopold, Christine; Poblete, Sergio; Vogler, Sabine (2023): How to Price and to Reimburse Publicly Funded Medicines in Latin America? Lessons Learned from Europe. Journal of Law, Medicine & Ethics, 51 (S1). pp. 76-91

Vogler, Sabine; Salcher-Konrad, Maximilian; Habimana, Katharina (2023): Interface policies bridging outpatient and hospital sectors in Europe: can cross-sectorial collaboration in reimbursement and procurement improve access to affordable medicines? Expert Review of Pharmacoeconomics & Outcomes Research. DOI: 10.1080/14737167.2023.2237683

Steigenberger, Caroline; Windisch, Friederike; Vogler, Sabine (2023): MT7 Barriers and Facilitators for the Use of Point of Care Diagnostics in Patients With Respiratory Tract Infections in Outpatient Care Related to the Peri-Launch Phase. Value in Health, 26 (12). p. 428

Rodríguez Sánchez, Diana Ivonne; Vogler, Sabine (2023): Shortages of Medicines to Treat COVID-19 Symptoms during the First Wave and Fourth Wave: Analysis of Notifications Reported to Registers in Austria, Italy, and Spain. Pharmacy, 11 (4). p. 120

Vogler, Sabine; Windisch, Friederike (2022): Assessing, Pricing and Funding Point-of-Care Diagnostic Tests for Community-Acquired Acute Respiratory Tract Infections–Overview of Policies Applied in 17 European Countries. Antibiotics, 11 (18). p. 987

Vogler, Sabine; Bauer, Eveli; Habimana, Katharina (2022): Centralised Pharmaceutical Procurement: Learnings from Six European Countries. Applied Health Economics and Health Policy, 20. pp. 637-650

Vogler, Sabine; Zimmermann, Nina (2022): Design of value-added tax on medicines in 41 European countries. European Journal of Public Health, 32 (3). iii632

Zimmermann, Nina; Vogler, Sabine; Haasis, Manuel Alexander (2022): HPR117 Meta-Indicators for Analysing Pharmaceutical Systems: The PPRI Indicators. Value in Health, 25 (12). p. 253

Salcher-Konrad, Maximilian; Habimana, Katharina; Vogler, Sabine (2022): HPR199 Public Procurement of Medicines: A Taxonomy of Procurement Systems in Europe. Value in Health, 25 (12). p. 269

Perelman, Julian; Duarte-Ramos, Filipa; Melo Gouveia, António; Pinheiro, Luis; Ramos, Francisco; Vogler, Sabine; Céu, Mateus (2022): How do hospital characteristics and ties relate to the uptake of second-generation biosimilars? A longitudinal analysis of Portuguese NHS hospitals, 2015–2021. Expert Review of Pharmacoeconomics & Outcomes Research, 23 (1). pp. 99-109

Vogler, Sabine; Zimmermann, Nina (2022): Improving medicines access in Brazil through collaboration in the PPRI network. Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, 13 (2). p. 677

Vogler, Sabine (2022): Pharmaceutical regulation and policies in Austria. Rev Bras Farm Hosp Serv Saude [Internet], 13 (1). p. 639

Vogler, Sabine (2022): Prices of new medicines: International analysis and policy optionsPreise bei neuen Arzneimitteln: internationale Analysen und Handlungsoptionen. Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen, 175. pp. 96-102

Vogler, Sabine; Habimana, Katharina; Haasis, Manuel Alexander (2022): Purchasing medicines for the public sector: Evaluation of the performance of centralised procurement in Portugal. The International Journal of Health Planning and Management, 37 (4). pp. 2007-2031

Vogler, Sabine (2022): “Ready for the future?” – Status of national and cross-country horizon scanning systems for medicines in European countries. GMS German Medical Science, 20 (Doc05). DOI: 10.3205/000307

Vogler, Sabine (2021): Can we achieve affordable cancer medicine prices? Developing a pathway for change. Expert Review of Pharmacoeconomics & Outcomes Research. pp. 1-5

Vogler, Sabine; Zimmermann, Nina; Babar-Ud-Din, Zaheer; Busse, Reinhard; Espin Balbino, Jaime; Mantel-Teeuwisse, Aukje; Panteli, Dimitra; Suleman, Fatima; Wirtz, Veronika J. (2021): Addressing the medicines access challenge through balance, evidence, collaboration and transparency: key take-away lessons of the 4th PPRI Conference. Journal of Pharmaceutical Policy and Practice, 14 (18).

Vogler, Sabine; Haasis, Manuel Alexander; van den Harn, Rianne; Humpert, Tifenn; Garner, Sarah; Suleman, Fatima (2021): European collaborations on medicine and vaccine procurement. Bull World Health Organ, 99 (10). pp. 715-721

Vogler, Sabine; Schneider, Peter; Zuba, Martin; Busse, Reinhard; Panteli, Dimitra (2021): Policies to Encourage the Use of Biosimilars in European Countries and Their Potential Impact on Pharmaceutical Expenditure. Frontiers in Pharmacology, 12.

Vogler, Sabine; Fischer, Stefan (2020): How to address medicines shortages: Findings from a cross-sectional study of 24 countries. Health Policy. doi.org/10.1016/j.healthpol.2020.09.001

Gamba, Simona; Pertile, Paolo; Vogler, Sabine (2020): The impact of managed entry agreements on pharmaceutical prices. Health Economics. doi.org/10.1002/hec.4112

Rintoul, Andrew; Colbert, Allison; Garner, Sarah; Kotwani, Anita; Vogler, Sabine; Bouvy, Jacoline; Hill, Andrew (2020): Medicines with one seller and many buyers: strategies to increase the power of the payer. BMJ, 369 (m1705). doi.org/10.1136/bmj.m1705

Vogler, Sabine (2020): Ein globales Problem. Gesundheit und Gesellschaft - Spezial. Das AOK-Forum für Politik, Praxis und Wissenschaft, 23 (12). p. 11

Vogler, Sabine; Schneider, Peter; Lepuschütz, Lena (2020): Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation. Cost Effectiveness and Resource Allocation, 18 (51). pp. https://doi.org/10.1186/s12962-020-00247-3

Gombocz, Margit; Vogler, Sabine (2020): Public spending on orphan medicines: a review of the literature. Journal of Pharmaceutical Policy and Practice, 13 (66). pp. doi.org/10.1186/s40545-020-00260-0

Vogler, Sabine; Kos, Mitja; Mardetko, Nika (2019): Review of studies reporting actual prices for medicines. Expert Review of Pharmacoeconomics & Outcome Research, 19 (2). pp. 159-179

Vogler, Sabine; Bak Pedersen, Hanne; Dedet, Guillaume (2019): Financial Burden of Prescribed Medicines Included in Outpatient Benefits Package Schemes: Comparative Analysis of Co-Payments for Reimbursable Medicines in European Countries. Applied Health Economics and Health Policy volume (17). pp. 803-816

Zimmermann, Nina; Haasis, Alexander; Balbino, Espin; Babar, Zaheer-Ud-Din; Vogler, Sabine; Busse, Reinhard; Mantel-Teeuwisse, Aukje; Suleman, Fatima (2019): Can pharmaceutical pricing and reimbursement policies make a difference in promoting equitable access to affordable medicines? Journal of Pharmaceutical Policy and Practice. ISSN 2052-3211

Vogler, Sabine (2019): Il miglioramento dei processi, la cooperazione, l’evidenza e la trasparenza: i temi chiave per le proposte di riforma delle politiche sul prezzo e rimborso dei farmaci. Politiche Sanitarie, 20 (4). pp. 180-182 ISSN 2038-1832

Vogler, Sabine; Bak Pedersen, Hanne; Dedet, Guillaume; Schneider, Peter (2019): Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan. International Journal for Equity in Health, 18 (89). ISSN 1475-9276

Vogler, Sabine (2019): Fair Prices for medicines? Exploring competent authorities and public payers preferences on pharmaceutical policies. Empirica - Journal of European Economics, 46 (3). pp. 443-469

Benslaoui, Bouchra; Zerhouni, Mohammed Wadie; Chikhaoui, Anas; Fouila, Fatima Zahra Ben; Habimana, Katharina; Hachri, Hafid; Bigdeli, Maryam; Vogler, Sabine; Taoufik, Jamal; Nejmi, Hicham (2019): Regulating medicine prices in Morocco - Effects of the medicine price decree 2014 on medicine prices. Journal of Pharmaceutical Policy and Practice. ISSN 2052-3211

Vogler, Sabine; Schneider, Peter (2019): Assessing Data Sources for Medicine Price Studies. International Journal of Technology Assessment in Health Care, 35 (2). pp. 106-115

Vogler, Sabine; Schneider, Peter; Zimmermann, Nina (2019): Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing. PharmacoEconomics - Open (3). pp. 303-309

Stürzlinger, Heidi; Röhrling, Isabella; Vogler, Sabine; Pilz, Eva; Eisenmann, Alexander (2018): Information Platform on Medication Safety within the Austrian Health Portal. Safety and Health, 4 (1). p. 11

Vogler, Sabine; de Rooij, Roger (2018): Medication wasted – Contents and costs of medicines ending up in household garbage. Research in Social and Administrative Pharmacy, 14 (12). pp. 1140-1146

Mardetko, Nika; Kos, Mitja; Vogler, Sabine (2018): Review of studies reporting actual prices for medicines. Expert review of pharmacoeconomics & outcomes research.

Book Section

Vogler, Sabine (2025): Chapter 3 - Evidence on pharmaceutical pricing policies in Europe. In: Formulating and Implementing Pharmaceutical Pricing Policies. Academic Press, https://doi.org/10.1016/B978-0-443-23518-4.00001-1, pp. 37-57

Vogler, Sabine; Panteli, Dimitra; Busse, Reinhard (2025): Preisbildung und Erstattungsmodelle von Arzneimitteln im internationalen Vergleich: Erkenntnisse für Deutschland. In: Arzneimittel-Kompass 2025. Springer, Berlin, pp. 167-181

Iaru, Irina; Vogler, Sabine (2024): Managed introduction of new medicines in healthcare systems. In: Drug Utilization Research: Methods and Applications. Wiley, pp. 233-247

Vogler, Sabine (2024): Measuring price and expenditure in drug utilization. In: Drug Utilization Research: Methods and Applications. Wiley, pp. 137-147

Vogler, Sabine; Leopold, Christine; Suleman, Fatima; Wirtz, Veronika J. (2024): Medicines and pharmaceutical services. In: Implementing the Primary Health Care approach: a primer. World Health Organization, Geneva, pp. 249-272

Vogler, Sabine; Almarsdóttir, AnnaBirna (2024): Pharmaceutical policy and drug utilization. In: Drug Utilization Research: Methods and Applications. Wiley, pp. 225-233

Vogler, Sabine; Dicheva-Radev, S.; Panteli, Dimitra; Busse, Reinhard (2024): Überblick über Maßnahmen zur Förderung des Einsatzes von Biosimilars in europäischen Ländern. In: Arzneiverordnungs-Report 2023. Springer, Berlin, pp. 63-95

Vogler, Sabine (2023): Arzneimittelversorgung: Gesundheitspolitische Maßnahmen für faire Preise. In: Gesundheit für alle: Reflexionen und Zukunftstrends. Verlag Österreich, Wien, pp. 145-156, https://doi.org/10.33196/9783704692436-113

Vogler, Sabine; Panteli, Dimitra; Zimmermann, Nina; Busse, Reinhard (2023): Überblick über Maßnahmen zur Förderung des Einsatzes von Biosimilars in europäischen Ländern. In: Arzneiverordnungs-Report 2022. Aktuelle Daten, Kosten, Trends und Kommentare. Springer, Berlin, Heidelberg, pp. 57-81

Busse, Reinhard; Henschke, Cornelia; Panteli, Dimitra; Vogler, Sabine (2022): Arzneimittelmarkt und -versorgung in Deutschland im europäischen Vergleich. In: Arzneimittel-Kompass 2022. Springer, Berlin Heidelberg, pp. 279-303

Binder, Michael; Brandtner, Alexander; Götzl, Florentin; Neiß, Andreas; Nikolai, Verena; Philadelphy, Daniela; Renhardt, Martin; Salcher-Konrad, Maximilian; Schörghofer, Volker; Thalhammer, Florian; Vogler, Sabine; Wagner, Oswald; Wenisch, Christoph; Wild, Claudia; Wirthumer-Hoche, Christa; Zeitlinger, Markus (2022): Therapien. In: Variantenmanagementplan. Konsolidierte Fassung der Ergebnisse des Expert:innenworkshops, Überarbeitungen der GÖG sowie Anmerkungen GECKO, Bundesländer und weiterer Systempartner:innen. Bundeskanzleramt Österreich, Wien, pp. 80-89

Vogler, Sabine (2022): Zugang zu leistbaren Arzneimitteln und Impfstoffen: Welchen Beitrag können innovative Pharmaökonomie und Arzneimittelpolitik leisten? In: Gesundheitspolitik und Gesellschaft in der COVID-19-Krise. Eine globale Herausforderung. Lit-Verlag, Münster, pp. 117-133 ISBN 978-3-643-51100-3

Vogler, Sabine; Panteli, Dimitra; Busse, Reinhard (2021): Biologika und Biosimilars in Deutschland und im europäischen Vergleich – Marktsteuerungsmechanismen und Preisvergleich. In: Arzneiverordnungs-Report 2021. Springer, Berlin, Heidelberg, pp. 75-107

Vogler, Sabine (2021): Preisregulierungen im internationalen Vergleich. In: Arzneimittel-Kompass 2021. Hochpreisige Arzneimittel – Herausforderung und Perspektiven [Medicines Compass 2021. High-priced medicines – Challenge and perspectives]. Springer, pp. 125-158

Vogler, Sabine; Schneider, Peter; Panteli, Dimitra; Busse, Reinhard (2020): Biosimilars in Deutschland und im europäischen Vergleich – Marktsteuerungsmechanismen und Einsparpotenziale. In: Arzneiverordnungs-Report 2020. Springer, Berlin, doi.org/10.1007 ISBN 978-3-662-62168-4

Vogler, Sabine (2020): Gratulation mit Wunschliste - Europäischer Blick aus dem Nachbarland. In: AMNOG-Report 2020. 10 Jahre AMNOG - Rückblick und Ausblick. Beiträge zur Gesundheitsökonomie und Versorgungsforschung, Bd 32 . medhochzwei, Bielefeld & Hamburg, pp. 196-208 ISBN 978-3-86216-722-7

Vogler, Sabine (2020): Medicines Pricing: Limitations of Existing Policies and New Models. In: Global Pharmaceutical Policy. Palgrave Macmillan, Singapur, pp. doi.org/10.1007/978-981

Vogler, Sabine; Schneider, Peter; Panteli, Dimitri; Busse, Reinhard (2019): Biosimilars in Deutschland und im europäischen Vergleich – Entwicklungen und Potenziale. In: Arzneiverordnungs-Report 2019. Springer, Berlin, Heidelberg

Vogler, Sabine (2018): Access to High-Cost Medicines in Europe. In: Equitable Access to High-Cost Pharmaceuticals. Elsevier, pp. 143-164

Bouvy, Jacoline; Vogler, Sabine (2013): Priority Medicine Report. Update on 2004 Background Paper 8.3. Pricing and Reimbursement Policies: Impacts on Innovation. In: Priority Medicines for Europe and the World "A Public Health Approach to Innovation". WHO, Wien

Monograph

Vogler, Sabine; Walter, Melanie; Knoll, Verena; Habimana, Katharina (2025): Capacity building to support the uptake of biosimilars in a multistakeholder approach – AUGMENT Biosimilars. Final study report. European Commission: European Health Digital Executive Agency. Publications Office of the European Union, Luxembourg

Vogler, Sabine; Walter, Melanie; Knoll, Verena; Habimana, Katharina (2025): Capacity building to support the uptake of biosimilars in a multistakeholder approach – Final study report. Annex 7, AUGMENT, Country fiches. European Commission: European Health Digital Executive Agency. Publications Office of the European Union, Luxembourg

Vogler, Sabine; Habimana, Katharina; Helter, Timea; Knoll, Verena; Kuriata, Elżbieta (2025): Capacity building to support the uptake of biosimilars in a multistakeholder approach – Final study report. Annexes 1-6 & 8-11. European Commission: European Health Digital Executive Agency. Publications Office of the European Union, Luxembourg

Vogler, Sabine (2025): PPRI Pharma Brief: Germany 2025. Pharmaceutical Pricing and Reimbursement Information (PPRI) Pharma Briefs Series. Gesundheit Österreich (National Public Health Institute), Wien

Salcher-Konrad, Maximilian; Helter, Timea; Vogler, Sabine (2024): Öffentliche Beschaffung von Arzneimitteln: Beschaffungspraktiken in Österreich und im europäischen Vergleich. Factsheet. Gesundheit Österreich, Wien

Windisch, Friederike; Zimmermann, Nina; Knoll, Verena; Habimana, Katharina; Vogler, Sabine (2023): Glossary of medical devices availability terms: Working definitions of terms for the “Study supporting the monitoring of availability of medical devices on the EU market”. Gesundheit Österreich, Wien

Windisch, Friederike; Zimmermann, Nina; Habimana, Katharina; Steigenberger, Caroline; Vogler, Sabine (2023): Glossary of single-use devices and reprocessing terms: Working definitions of terms for the “Study on the implementation of Article 17 of Regulation (EU) 2017/745 on medical devices on the EU market”. Factsheet. Gesundheit Österreich, Wien

Salcher-Konrad, Maximilian; Knoll, Verena; Vogler, Sabine (2023): Leistungsspektrum der öffentlichen Apotheken im österreichischen Gesundheitssystem – Bestandsaufnahme, Analyse und Ausblick. Gesundheit Österreich, Wien

Salcher-Konrad, Maximilian; Fischer, Stefan; Knoll, Verena; Vogler, Sabine (2023): Leistungsspektrum der öffentlichen Apotheken in Österreich – Bestandsaufnahme und Analyse. Factsheet. Gesundheit Österreich, Wien

Vogler, Sabine; Salcher-Konrad, Maximilian; Knoll, Verena (2023): Leistungsspektrum der öffentlichen Apotheken – internationaler Vergleich. Factsheet. Gesundheit Österreich, Wien

Windisch, Friederike; Zimmermann, Nina; Habimana, Katharina; Knoll, Verena; Vogler, Sabine (2023): One-pager (long version) on “Study supporting the monitoring of the availability of medical devices on the EU market (MD Availability)”. Gesundheit Österreich, Wien

Windisch, Friederike; Zimmermann, Nina; Habimana, Katharina; Knoll, Verena; Fischer, Stefan; Vogler, Sabine (2023): One-pager (long version) “Study on the implementation of Article 17 of Regulation (EU) 2017/745 on medical devices on the EU market (single-use devices)”. Factsheet. Gesundheit Österreich, Wien

Windisch, Friederike; Zimmermann, Nina; Habimana, Katharina; Fischer, Stefan; Knoll, Verena; Vogler, Sabine (2023): One-pager (short version) on “Study on the implementation of Article 17 of Regulation (EU) 2017/745 on medical devices on the EU market (single-use devices). Factsheet. Gesundheit Österreich, Wien

Fischer, Stefan; Knoll, Verena; Alleweldt, Frank; Vogler, Sabine (2023): Potential measures to facilitate the production of active pharmaceutical ingredients (APIs). Publication for the Committee on the Environment, Public Health and Food Safety, Policy Department for Economic, Scientific and Quality of Life Policies, European Parliament, Luxembourg

European Commission, European Health and Digital Executive Agency; Vogler, Sabine; Salcher-Konrad, Maximilian; Habimana, Katharina (2023): Study on best practices in the public procurement of medicines. Annex 4, PPM country fiches. Publications Office of the European Union, https://data.europa.eu/doi/10.2925/28086

European Commission, European Health and Digital Executive Agency; Vogler, Sabine; Salcher-Konrad, Maximilian; Habimana, Katharina (2023): Study on best practices in the public procurement of medicines. Annexes 1-3 & 5-11. Publications Office of the European Union, https://data.europa.eu/doi/10.2925/822369

Steigenberger, Caroline; Vogler, Sabine; Windisch, Friederike; Zimmermann, Nina (2022): Recommendations for innovative fit for purpose pricing and funding models for CA-ARTI diagnostics (Tastk 5.4). Value-DX Consortium/Gesundheit Österreich, Wien

Habimana, Katharina; Haasis, Manuel Alexander; Vogler, Sabine (2022): The 75th World Health Assembly “Health for peace and peace for health". Briefing requested by the ENVI committee, doi:10.2861/588. European Parliament, Online

Vogler, Sabine (2022): Access to information in markets for medicines in the WHO European Region. Oslo Medicines Initiative technical report. World Health Organization. Regional Office for Europe, Copenhagen

Vogler, Sabine (2022): Access to information in markets for medicines in the WHO European Region. Web annex: country-specific fact sheets detailing access to information. World Health Organization, Copenhagen

Vogler, Sabine; Zimmermann, Nina; Windisch, Friederike (2022): PPRI Medical Devices Brief: France 2022. PPRI Medical Devices Briefs Series. Gesundheit Österreich, Wien

Vogler, Sabine (2022): Payer policies to support innovation and access to medicines in the WHO European Region. World Health Organization. Regional Office for Europe. Lizenz: CC BY-NC-SA 3.0 IGO, Copenhagen

Vogler, Sabine (2022): Payer policies to support innovation and access to medicines in the WHO European Region. Web-annex: case study of Italy’s policies for medical innovation. World Health Organization. Regional Office for Europe, Copenhagen

Vogler, Sabine; Salcher-Konrad, Maximilian; Habimana, Katharina (2022): Study on best practices in the public procurement of medicines. Final report. European Health and Digital Executive Agency: Publications Office of the European Union, Brussels

Webb, Erin; Richardson, Erica; Vogler, Sabine; Panteli, Dimitra (2022): What are the implications of policies increasing transparency of prices paid for pharmaceuticals? World Health Organization. Regional Office for Europe, Copenhagen

Vogler, Sabine; Schneider, Peter; Fischer, Stefan; Haasis, Manuel Alexander; Heindl, Bettina; Windisch, Friederike (2021): Preisvergleich ausgabenstarker Arzneispezialitäten 2019. Gesundheit Österreich, Wien

Vogler, Sabine; Habimana, Katharina; Bauer, Eveli; Schneider, Peter; Haasis, Manuel Alexander (2021): Assessment of Centralised Procurement of Medicines in Portugal. Gesundheit Österreich, Wien

Vogler, Sabine; Habimana, Katharina; Bauer, Eveli; Schneider, Peter; Haasis, Manuel Alexander (2021): Avaliação das Aquisições Centralizadas dos Medicamentos em Portugal – Relatório de Síntese. Gesundheit Österreich, Wien

Vogler, Sabine; Haasis, Manuel Alexander; Zimmermann, Nina (2021): Financial burden of medicines for patients: Co-payments and protective measures in European countries. Factsheet prepared for the European Public Health Week 2021. Gesundheit Österreich, Wien

Fischer, Stefan; Vogler, Sabine; Windisch, Friederike; Zimmermann, Nina (2021): HTA, Reimbursement and Pricing of Diagnostic Tests for CA-ARTI. An international overview of policies (Task 5.5). Value-DX Consortium/Gesundheit Österreich, Wien

Vogler, Sabine; Habimana, Katharina; Fischer, Stefan; Haasis, Manuel Alexander (2021): National Policy Options for New AMR Health Technologies. Based on the study. Policy Brief #01. Global AMR R&D Hub, Wien

Vogler, Sabine; Habimana, Katharina; Fischer, Stefan; Haasis, Manuel Alexander (2021): Novel policy options for reimbursement, pricing and procurement of AMR health technologies. Gesundheit Österreich, Wien

Vogler, Sabine (2021): PPRI Pharma Brief: Italy 2021. Gesundheit Österreich, Wien

Vogler, Sabine (2020): PPRI Pharma Brief: Spain 2020. Pharmaceutical Pricing and Reimbursement Information (PPRI) Pharma Briefs Series. Gesundheit Österreich, Wien

Vogler, Sabine (2020): PPRI Pharma Brief: France 2020. Pharmaceutical Pricing and Reimbursement Information (PPRI) Pharma Briefs Series. Gesundheit Österreich, Wien

Vogler, Sabine; Fischer, Stefan (2020): Lieferengpässe bei Arzneimitteln: Internationale Evidenz und Empfehlungen für Deutschland. Kurzgutachten. Gesundheit Österreich, Wien

Vogler, Sabine; Zimmermann, Nina; Dedet, Guillaume; Lam, Janice; Bak Pedersen, Hanne (2020): Pharmaceutical Pricing and reimbursement systems in Eastern Europe and Central Asia. WHO Regional Office for Europe, Kopenhagen

Vogler, Sabine; Haasis, Manuel Alexander; Zimmermann, Nina (2019): PPRI Pharma Brief: Austria 2019. Gesundheit Österreich, Wien

Windisch, Friederike; Haasis, Manuel Alexander; Schneider, Peter; Vogler, Sabine (2019): Preisvergleich ausgabenstarker Arzneispezialitäten 2019 - Studienprotokoll. Gesundheit Österreich, Wien

Vogler, Sabine; Schneider, Peter; Zimmermann, Nina (2019): Estimating Real Prices of Medicines used in Hospitals - Study protocol. Gesundheit Österreich, Wien

Vogler, Sabine; Zimmermann, Nina; Haasis, Manuel Alexander (2019): PPRI Report 2018 - Pharmaceutical pricing and reimbursement policies in 47 PPRI network member countries. WHO Collaborating Centre for Pricing and Reimbursement Policies. Gesundheit Österreich, Wien

Schneider, Peter; Vogler, Sabine; Zimmermann, Nina; Zuba, Martin (2018): Preisvergleich ausgabenstarker Arzneispezialitäten 2017. Gesundheit Österreich, Wien

Vogler, Sabine; Paris, Valérie; Panteli, Dimitra (2018): Ensuring access to medicines: How to redesign pricing, reimbursement and procurement? Policy Brief No. 30. World Health Organization, Copenhagen

Vogler, Sabine; Schneider, Peter; Zimmermann, Nina (2017): Price comparison of high-cost medicines 2017.Study protocol. Gesundheit Österreich, Vienna

Vogler, Sabine; Schneider, Peter; Zimmermann, Nina (2016): Preisvergleich kostenintensiver Arzneimittel 2015. Gesundheit Österreich GmbH, Wien

Panteli, Dimitra; Arickx, Francis; Cleemput, Irina; Dedet, Guillaume; Eckhardt, Helene; Fogarty, Emer; Gerkens, Sophie; Henschke, Cornelia; Hislop, Jennifer; Jommi, Claudio; Kaitelidou, Daphne; Kawalec, Pawel; Keskimäki, Ilmo; Kroneman, Madelon; Bastida, Julio Lopez; Barros, Pedro Pita; Ramsberg, Joakim; Schneider, Peter; Spillane, Susan; Vogler, Sabine; Vuorenkoski, Lauri; Kildemoes, Helle Wallach; Wouters, Olivier; Busse, Reinhard (2016): Pharmaceutical regulation in 15 European countries. Review. European Observatory on Health Systems and Policies

Vogler, Sabine; Lepuschütz, Lena; Schneider, Peter; Stühlinger, Verena (2015): Study on enhanced cross-country coordination in the area of pharmaceutical product pricing. Final report. Gesundheit Österreich, Wien

Ostermann, Herwig; Renner, Anna-Theresa; Bobek, Julia; Schneider, Peter; Vogler, Sabine (2015): A cost/benefit analysis of selfcare systems in the European Union. European Commission, DG Sante

Vogler, Sabine; Habimana, Katharina (2014): Pharmaceutical pricing policies in European countries. Gesundheit Österreich Forschungs- und Planungs GmbH, Wien

Vogler, Sabine; Zimmermann, Nina; Habimana, Katharina (2014): Study of the policy mix for the reimbursement of medicinal products. Proposal for a best practice-based approach based on stakeholder assessment. Gesundheit Österreich Forschungs- und Planungs GmbH und SOGETI, Wien

Vogler, Sabine (2014): Liberalization in the Pharmacy Sector. OECD Global Forum on Distribution, Paris

Vogler, Sabine; Schmickl, Bettina; Zimmermann, Nina (2013): Short PPRI / PHIS Pharma Profile. Austria 2013. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien

Zimmermann, Nina; Vogler, Sabine (2012): PPRI / PHIS Pharma Profile. Austria 2012. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien

Vogler, Sabine; Arts, Danielle; Sandberger, Katharina (2012): Impact of pharmacy deregulation and regulation in European countries. Gesundheit Österreich Forschungs- und Planungs GmbH, Wien

Zuidberg, Christel; Vogler, Sabine; Mantel, A (2010): The pharmaceutical system of the Netherlands. A comparative analysis between the Dutch out-patient pharmaceutical system, in particular the pricing and reimbursement characteristics, and those of the other European Union Member States, with a special focus on tendering-like systems. Gesundheit Österreich GmbH, Wien

Morak, Simone; Vogler, Sabine; Walser, Sabine; Kijlstra, Nico (2010): The pharmaceutical system of the Netherlands and Applying it in Practice. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien

Vogler, Sabine; Schmickl, Bettina (2010): Rationale Arzneimitteltherapie in Europa. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien

Vogler, Sabine; Leopold, Christine (2010): Pharmaceutical Country Profile. Austria. Gesundheit Österreich GmbH, Wien

Leopold, Christine; Habl, Claudia; Morak, Simone; Rosian-Schikuta, Ingrid; Vogler, Sabine (2008): Leistungsfähigkeit des österreichischen Gesundheitssystems im Vergleich. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien

Habl, Claudia; Vogler, Sabine; Leopold, Christine; Schmickl, Bettina; Fröschl, Barbara (2008): Referenzpreissysteme in Europa. ÖBIG Forschungs- und Planungsgesellschaft mbH, Wien

Vogler, Sabine; Antony, Katja; Arts, Danielle; Habl, Claudia; Fröschl, Barbara; Leopold, Christine; Rosian-Schikuta, Ingrid; Stürzlinger, Heidi; Weigl, Marion (2006): Pharmaceutical Systems In The European Union 2006. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien

Habl, Claudia; Antony, Katja; Arts, Danielle; Entleitner, Michael; Fröschl, Barbara; Leopold, Christine; Stürzlinger, Heidi; Vogler, Sabine; Weigl, Marion (2006): Surveying, Assessing and Analysing the Pharmaceutical Sector in the 25 EU Member States. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien

Vogler, Sabine; Arts, Danielle; Habl, Claudia (2006): Community Pharmacy In Europe. Lessons from deregulation – case studies. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien

Vogler, Sabine; Antony, Katja; Habl, Claudia; Leopold, Christine (2005): Arzneimittelsysteme in den neuen EU-Mitgliedstaaten Estland, Lettland, Litauen, Malta, Polen, Slowakei, Slowenien, Tschechische Republik, Ungarn, Zypern. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien

Habl, Claudia; Schnabel, Eva; Vogler, Sabine; Rosian-Schikuta, Ingrid; Takacs, Adam (2004): Öffentliche Ausgaben für Prävention und Gesundheitsförderung in Österreich 2001. Bundesministerium für Gesundheit und Frauen, Wien

Rosian-Schikuta, Ingrid; Mildschuh, Stephan; Vogler, Sabine; Winkler, Petra; Antony, Katja (2002): Selbstbeteiligung. Internationaler Vergleich und Implikationen für Österreich. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien

Vogler, Sabine; Habl, Claudia; Kranvogel-Zellermayer, Edith; Rosian-Schikuta, Ingrid (2000): Apothekenleistungen im europäischen Vergleich. Kurzfassung. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien

Vogler, Sabine; Habl, Claudia (2000): E-Pharma. Arzneimittelvertrieb im Internet. Kurzfassung. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien

Conference or Workshop Item

Vogler, Sabine (2025): Capacity building to support the uptake of biosimilars in a multistakeholder approach (AUGMENT Biosimilars) - Country experience and learnings from AUGMENT. OECD | WPRO webinar: Promoting the adoption of biosimilar medicines in Asia-Pacific, 11. Dezember 2025, online

Vogler, Sabine (2025): Capacity building to support the uptake of biosimilars in a multistakeholder approach (AUGMENT Biosimilars). European Competition Network (ECN) Meeting Pharma & Health Services Subgroup, 10. Dezember 2025, online

Vogler, Sabine (2025): Koordinierte Finanzierung von Medikamenten zwischen Versorgungsbereichen. imh online: „Market Access & Erstattung", 9. Dezember 2025, online

Vogler, Sabine (2025): Capacity building to support the uptake of biosimilars in a multistakeholder approach (AUGMENT Biosimilars). Session organised by the AUGMENT Consortium. Biosimilars Multistakeholder Event, 4. Dezember 2025, online

Vogler, Sabine (2025): Early Access für Medikamente - Einordnung und internationaler Überblick. Pharma-Plattform, 13. November 2025, Wien

Vogler, Sabine (2025): Arzneimittelpreispolitik und internationale Preisvergleiche. Zertifikatslehrgang Gesundheitsjournalismus, 12. November 2025, Wien

Vogler, Sabine (2025): Ensuring affordable access to medicines through public procurement in Europe? WHO Global Forum for Public Procurement of Health Products, 5. November 2025, hybrid

Vogler, Sabine (2025): Looking back on 20 years of PPRI - Challenges and contributions in a dynamic environment. PPRI@20 Symposium, 16 September 2025, Wien

Vogler, Sabine (2025): Ensuring sustainable and equitable patient access to affordable medicines – Do we need innovation in policy-making? European Drug Utilization (EuroDURG) Conference 2025, 4. Juli, Uppsala

Knoll, Verena; Steigenberger, Caroline; Fischer, Stefan; Vogler, Sabine (2025): Made in Europe - Assessing the feasibility of reshoring active pharmaceutical ingredient (API) production to Europe. European Drug Utilization Conference 2025: Bridging Data, Policy & Patients in Drug Utilization Research, 2. Juli 2025, Uppsala

Vogler, Sabine (2025): Stärkung des Biosimilar-Wettbewerbs und des Uptakes in Europa – aktuelle Initiativen und Projekte. Market Access Generika & Biosimilars 2025, 4. Juni 2025, online

Vogler, Sabine (2025): Update on AUGMENT Biosimilars Project – Capacity building to support the uptake of biosimilars in a multistakeholder approach & Comments on OECD study on impact of advertising regulations on biosimilar uptake. OECD Expert Group on Pharmaceuticals and Medical Devices, 16. Mai 2025, Paris

Vogler, Sabine; Salcher-Konrad, Maximilian; Knoll, Verena (2025): Community pharmacy in Austria:- Status-quo and developments regarding the services in an international comparison. ATHEA Conference 2025, 7. März 2025, Wien

Knoll, Verena; Steigenberger, Caroline; Fischer, Stefan; Vogler, Sabine (2025): Made in Europe - Assessing the feasibility of reshoring active pharmaceutical ingredient (API) production to Europe. 8th ATHEA Conference: Status quo and new directions for Austrian health economics, 7. März 2025, Wien

Vogler, Sabine; Knoll, Verena; Perelman, Julian; Kuriata, Elżbieta (2024): Capacity building to support the uptake of biosimilars in a multistakeholder approach (AUGMENT Biosimilars). Biosimilars Multistakeholder Event, 5. Dezember 2024, Brüssel

Vogler, Sabine (2024): Arzneimittelpreispolitik und internationale Preisvergleiche. Zertifikatslehrgang Gesundheitsjournalismus, 13. November 2024, Wien

Vogler, Sabine (2024): Introduction to the EU4Health AUGMENT Biosimilars capacity-building project. Meeting of the National Competent Authorities on Pricing and Reimbursement and Public Healthcare Payers (NCAPR), 9. Oktober 2024, Budapest

Vogler, Sabine (2024): PPRI Update. Meeting of the National Competent Authorities on Pricing and Reimbursement and Public Healthcare Payers (NCAPR), 9. Oktober 2024, Budapest

Vogler, Sabine (2024): Medicine shortages: Government policy measures and developments. Office of Health Econonomics (OHE) Webinar: Drug Shortages: What are the causes, consequences and pathways to a solution, 24. September 2024, online

Vogler, Sabine (2024): Arzneimittelversorgung in Österreich. Studienbesuch des Ausschusses für Soziales, Arbeit, Gesundheit und Gleichstellung für das Land Niedersachsen, 10. September 2024, Wien

Vogler, Sabine (2024): HTA & Policy: Recommendations related to funding, pricing, and procurement to enhance the use of Point-of-Care Tests for CA-LRTI. VALUE-DX Closing Conference, 5. September 2024, Valencia

Vogler, Sabine (2024): Findings from a Pharmaceutical Pricing and Reimbursement Information (PPRI) Network query: Tackling medicine shortages during and after the COVID-19 pandemic. EMA Medicine Shortages Single Point of Contact Working Party, 17. Juli 2024, online

Vogler, Sabine (2024): Medicines and pharmaceutical services. A changing role in primary health care. Broadening the role of pharmaceutical services in primary care Webinar organised by the European Observatory on Health Systems and Policies, 27. Juni 2024, online

Vogler, Sabine (2024): Transparency of cancer medicine prices and rebates. OECI 2024 Oncology Days, 14. Juni 2024, Helsinki

Vogler, Sabine (2024): Presentation of the Austrian pharmaceutical system. PPRI Conference 2024. Workshop on Access to new and expensive medicines in Austria: what role for the new “appraisal board”?, 26. April 2024, Wien

Vogler, Sabine (2024): Best Practices for Sustainable Pricing and Procurement of Medicines. Policy Dialogue – CEI: Building resilient pharmaceutical and health product systems, 18. April 2024, Triest

Vogler, Sabine (2024): Country-level government policies to address medicine shortages. Policy Dialogue – CEI: Building resilient pharmaceutical and health product systems, 18. April 2024, Triest

Vogler, Sabine (2024): Basics of medicines pricing. Webinar hosted by Myeloma Patients Europe (MPE), as part of the ASCERTAIN project, 7. März 2024, online

Vogler, Sabine; Zimmermann, Nina; Haasis, Manuel Alexander; Gombocz, Margit; Knoll, Verena (2024): Approaching two decades of information sharing between competent authorities: Experience from the Pharmaceutical Pricing and Reimbursement Information (PPRI) network. Poster. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, 25.-26. April 2024, Wien

Vogler, Sabine; Salcher-Konrad, Maximilian; Knoll, Verena (2024): Community pharmacy in Austria, England, Estonia and Portugal: Has the COVID-19 pandemic changed the range of pharmacy services offered? Poster. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, 25.-26. April 2024, Wien

Vogler, Sabine (2024): Increasing prices to ensure availability of medicines? Financial incentives implemented as shortage mitigation policy in PPRI member countries. Poster. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, 25.-26. April 2024, Wien

Knoll, Verena; Steigenberger, Caroline; Fischer, Stefan; Vogler, Sabine (2024): Made in Europe - assessing the feasibility of reshoring active pharmaceutical ingredient (API) production to Europe. Poster. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, 25.-26. April 2024, Wien

Salcher-Konrad, Maximilian; Fischer, Stefan; Knoll, Verena; Vogler, Sabine (2024): Pharmaceutical care in Austria: A survey on services provided by community pharmacies. Poster. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, 25.-26. April 2024, Wien

Leopold, Christine; Vogler, Sabine; Suleman, Fatima; Wirtz, Veronika J. (2024): Strengthening primary health care through a stronger emphasis on patient and community centered medicines and pharmaceutical services. Poster. 5th PPRI conference 2024: Ensuring access to affordable medicines through innovative policies, 25.-26. April 2024, Wien

Salcher-Konrad, Maximilian; Vogler, Sabine; Habimana, Katharina (2024): Use of strategic approaches in public procurement of medicines: improving affordable patient access to medicines and protecting the environment in 32 European countries. 5th PPRI Conference, 25. April 2024, Wien

Vogler, Sabine (2023): Challenges and good practice examples in pricing, reimbursement and demand-side measures to enhance the uptake of biosimilar medicines. 7th Multi-stakeholder Event on Biosimilar Medicines, 13. Dezember 2023, Brüssel

Vogler, Sabine (2023): Introduction to Resolution WHA72.8 with respect to implementation in the WHO European Region. Novel Medicines Platform (NMP), Working Group 1: Transparency, 5. Dezember 2023, Brüssel

Vogler, Sabine (2023): Pharmaceutical pricing and reimbursement policies. International Master of Science in Sustainable Drug Discovery, 1. Dezember 2023, Gent

Vogler, Sabine (2023): Innovative Erstattungsmodelle. imh-PHARMAKON-Konferenz, 23. November 2023, Mauerbach

Vogler, Sabine (2023): Secrecy of price discounts: a facilitator or barrier to access? Meeting on Revising procedure for updating WHO’s Model List of Essential Medicines, 3. November 2023, Genf

Vogler, Sabine (2023): Horizon scanning of medicines: Overview article. Subgroup for Identification of Emerging Health Technologies (EHT), 6. Oktober 2023, online

Vogler, Sabine (2023): Study for the European Parliament “Potential measures to facilitate productions of active pharmaceutical ingredients (APIs)”. “Made in Europe”, 29. September 2023, Graz

Vogler, Sabine (2023): Study for the European Parliament “Potential measures to facilitate productions of active pharmaceutical ingredients (APIs)”. "Made in Europe", 29. September 2023, Graz

Vogler, Sabine (2023): Fake prices –Is there still a role for medicine price studies? Department of Health Economics (DHE) 10th Anniversary Symposium, 25. September 2023, Wien

Vogler, Sabine; Zimmermann, Nina (2023): Zugang zu Arzneimitteln: Wie kommen Medikamente auf den Markt, und wie kommen Patientinnen und Patienten an die Medikamente? ÖKUSS Webinar, 20. September 2023, online

Vogler, Sabine (2023): Pharmaceutical Pricing and Reimbursement Information (PPRI) network shortage survey results. Medicine Shortages (SPOC) Working Party, 6. Juli 2023, online

Vogler, Sabine (2023): Preisregulierung und nachfrageseitige Maßnahmen im Bereich der Biosimilars im internationalen Vergleich. Biosimilars 2023 – die Aut-idem- Regeln, 5. Juli 2023, online

Vogler, Sabine (2023): Preisbildung und Erstattung von Arzneimitteln in Europa. Modul "Industrie", Management im Gesundheitswesen, 3. Juli 2023, Berlin

Vogler, Sabine; Wettermark, Björn (2023): Challenges with new medications. EuroDURG Conference 2023, 29. Juni 2023, Bologna

Vogler, Sabine (2023): Best Practices for Sustainable Pricing and Procurement of Medicines. Policy Dialogue - CAR “Ensuring sustainable and affordable access to medicines”, 18. April 2023, Almaty

Vogler, Sabine (2023): Wirkstoffverordnung: Internationale Entwicklungen im Vergleich. Frühjahrsversammlung der Arbeitsgemeinschaft Österreichischer Krankenhausapotheker, 14. April 2023, Wien

Vogler, Sabine (2023): Spielen Umweltkriterien in der öffentlichen Arzneimittelbeschaffung eine Rolle? Status-Quo und Erfahrungen in 32 europäischen Ländern. EbM-Jahrestagung, 24. März 2023, Potsdam

Vogler, Sabine (2023): Gaps in Research & Policy. EFPN Steering Group meeting, 10. März 2023, Amsterdam

Vogler, Sabine (2023): Política do medicamento / Pharmaceutical policies. Economia da Saúde e Avaliação de Resultados em Saúde / Health Economics and Outcomes Research, Escola Nacional de Saúde Pública, 24. Februar 2023, Lissabon

Vogler, Sabine (2023): Improving access to affordable medicines Activities of the WHO Collaborating Centre for Pharmaceutical Pricing and Reimbursement Policies. CERGAS seminar, 16. Februar 2023, Mailand

Vogler, Sabine (2023): Best Practices for Sustainable Pricing and Procurement of Medicines. Policy Dialogue “Ensuring sustainable and affordable access to effective and novel medicines”, 25. Jänner 2023, Chisinau

Vogler, Sabine (2023): Can transparency improve access to medicines? State-of-play of publication of medicine prices and other market information in European countries. European Parliament, Committee on Petitions Meeting, 25. Jänner 2023, Brüssel/hybrid

Salcher-Konrad, Maximilian; Vogler, Sabine; Habimana, Katharina (2023): How to optimise public procurement of medicines? Lessons from a study on public procurement practices in 32 European countries. ATHEA Conference 2023, 23. Februar 2023, Wien

Vogler, Sabine; Salcher-Konrad, Maximilian (2023): Leistungsspektrum der öffentlichen Apotheken im österreichischen Gesundheitssystem. Bestandsaufnahme, Analyse und Ausblick. APOtag & APOkongress, 16. Juni 2023, Wien

Windisch, Friederike; Vogler, Sabine (2023): Medical Devices Glossary. Abbreviations, Terms, and Symbols. Posterpräsentation. EuroDURG 2023, 27. Juni 2023, Bologna

Vogler, Sabine; Salcher-Konrad, Maximilian (2023): Study on Best Practices in the Public Procurement of Medicines (PPM). Key findings. Webinar on best practices in the public procurement of medicines, 7. Februar 2023, Webinar

Steigenberger, Caroline; Vogler, Sabine; Windisch, Friederike; Zimmermann, Nina (2022): HTA, Reimbursement and Pricing of Diagnostic Tests for CA-ARTI. Key facilitators and barriers and recommendations for pricing and funding. Recommendations for innovative fit for purpose pricing and funding models for CA-ARTI Dx (Task 5.5, Deliverable 5.4). Value-Dx Annual Meeting and General Assembly Meeting, 7. September 2022, Bologna

Vogler, Sabine (2022): Biosimilar Policies in PPRI countries. Webinar on Biosimilar Policies in PPRI countries, 29. September 2022, online

Vogler, Sabine (2022): Biosimilar policies. WHO Essential Medicines List (EML) Cancer Working Group, 24. März 2022, online

Vogler, Sabine (2022): Blitzlicht auf erste Arbeiten der GÖG-Pharmaökonomie zum Thema "Ökologischer Fußabdruck: Welche Rolle spielen Arzneimittel". Pharma-Plattform, 27. Juni 2022, Wien

Habimana, Katharina; Haasis, Manuel Alexander; Vogler, Sabine (2022): Briefing on the 75th World Health Assembly: health for peace and peace for health” (Geneva, 22 to 28 May 2022). Briefing Meeting for European Parliamaent ENVI Committee Members, 19. Mai 2022, online

Vogler, Sabine; Salcher-Konrad, Maximilian (2022): How to optimise public procurement for medicines? Presentation of the preliminary results of the Study on Best Practices in the Public Procurement of Medicines (PPM). Meeting of the National Authorities on Pricing and Reimbursement and Public Healthcare Payers (NCAPR), 11. Oktober 2022, Webinar

Vogler, Sabine (2022): Internationale Entwicklungen in herausfordernden Zeiten. imh-pharmaKON-Konferenz, 22. November 2022, Mauerbach

Vogler, Sabine; Rodríguez Sánchez, Diana Ivonne (2022): Medicines to treat COVID-19 symptoms in short supply. Analysis of shortages registers in Austria, Italy and Spain during the first wave and fourth wave. European Health Economics Association (EuHEA) conference, 7. Juli 2022, Oslo

Zimmermann, Nina; Vogler, Sabine; Haasis, Manuel Alexander (2022): Meta-Indicators for Analysing Pharmaceutical Systems: The PPRI Indicators. Posterpräsentation. ISPOR 2022, 9. November 2022, Wien

Vogler, Sabine (2022): New payment models for medicines. Introductory overview. Network of Competent Authority of Pricing and Reimbursement (NCAPR) meeting, 20. Juni 2022, Brüssel/online

Vogler, Sabine (2022): New payment models for potentially innovative medicines and country experiences. PPRI Online Network Meeting, 4. Mai 2022, online

Vogler, Sabine; Zimmermann, Nina (2022): Policies to enhance use of biosimilar medicines in 50 countries. Can policy makers draw on learnings from generic policies? European Health Economics Association (EuHEA) Conference, 7. Juli 2022, Oslo

Vogler, Sabine (2022): Policies to support innovation and access to medicines in the WHO European Region. Oslo Medicines Initiative (OMI) Webinar #2: Models for financing novel medicinesto support innovation as a public good, 20. Jänner 2022, online

Vogler, Sabine (2022): Price transparency. Vancouver Group Meeting, 15. September 2022, Wien

Vogler, Sabine (2022): Price transparency. Oslo Medicines Initiative (OMI) webinar 3: Pricing, reimbursement and coverage policies for sustainable access to affordable innovative medicines, 27. Jänner 2022, online

Salcher-Konrad, Maximilian; Habimana, Katharina; Vogler, Sabine (2022): Public Procurement of Medicines: A Taxonomy of Procurement Systems in Europe. Posterpräsentation. ISPOR 2022, 9. November 2022, Wien

Vogler, Sabine; Steigenberger, Caroline (2022): Recommendations related to Funding, Pricing and Procurement to enhance uptake of POC diagnostic tests. Webinar on the VALUE-Dx project and the policy recommendations, 25. Oktober 2022, online

Vogler, Sabine (2022): Spotlight on transparency. Increasing transparency of prices paid for pharmaceuticals: what might happen? Launch of Policy Brief on Net Price Transparency for Pharmaceuticals, 17. Mai 2022, online

Vogler, Sabine; Salcher-Konrad, Maximilian (2022): Study on Best Practices in the Public Procurement of Medicines (PPM). Network of Competent Authority of Pricing and Reimbursement (NCAPR) meeting, 11. Oktober 2022, online

Vogler, Sabine (2022): Transparency in pharmaceutical markets. What does it mean and why should we care? Baltic Policy Dialogue, 14. November 2022, Vilnius

Vogler, Sabine (2022): Zugang und Finanzierung von hochpreisigen Arzneimitteln. imh-Online-Seminar „Market Access und Erstattung, 5. April 2022, online

Vogler, Sabine (2021): EU Pharmaceutical Straetgy. imh Online „Market Access & Erstattung“, 14. Dezember 2021, online

Vogler, Sabine (2021): National perspectives on cross-border initiatives and joint EU level procurement in the field of medicines. European Cross-border Initiatives: Toward Fair Medicine Deals?, organised by Association of European Cancer Leagues (ECL), the European Fair Pricing Network (EFPN) and the European Public Health Alliance (EPHA), 9. Dezember 2021, online

Vogler, Sabine (2021): Medicines shortages of COVID-19 relevant medication in Italy, Austria and Spain during the first months of the pandemic. Convegno annuale AIES (Associazione Italiana di Economia Sanitaria), 3. Dezember 2021, Mailand / online (hybrid)

Vogler, Sabine (2021): Preise bei neuen Arzneimitteln. Trends, Vergleiche, Analysen. IQWIG-Herbst-Symposium, 26. November 2021, Köln/Online

Vogler, Sabine (2021): Internationale Entwicklungen in herausfordernden Zeiten. imh PharmaKON 2021, 24. November 2021, Wien

Vogler, Sabine (2021): Challenges of pricing new cancer medicines. Internal international webinar organised by NKI (Dutch Cancer Institute), 5. November 2021, Online

Vogler, Sabine (2021): EU centralised procurement. Virtual Exchange Forum on Medicines Procurement organised by EAHP, 21. Oktober 2021, online

Vogler, Sabine (2021): Centralised procurement of medicines and vaccines – European comparative analysis and success factors. 6. Konferenz der Austrian Health Economics Association (ATHEA), 24. September 2021, Wien

Vogler, Sabine (2021): Is the grass always greener on the other side? History, rationale, and the dos and don’ts of external reference pricing. Experience on Austria. WHO-Webinar on Country pharmaceutical pricing policies, 11. August 2021, online

Vogler, Sabine (2021): Solutions for preventing and mitigating the impact of shortages in the EU. Future-proofing pharmaceutical legislation – study on medicine shortages. Final consultation event, 1. Juli 2021, Online

Vogler, Sabine (2021): Access to innovative cancer medicines in Europe. Organisation of European Cancer Institutes (OECI) Oncology Days, 16. Juni 2021, Online

Vogler, Sabine; Zimmermann, Nina (2021): Financial burden of medicines for patients: Co-payments and protective measures in European countries. Webinar zum Tagesmotto: Leaving no one behind im Rahmen der European Public Health Week 2021, 21. Mai 2021, Online

Vogler, Sabine (2021): Hochpreisige Arzneimittel - Internationale Lösungsansätze. BKK Werkstattgespräch, 30. April 2021, Online-Konferenz

Vogler, Sabine (2021): Promoting the use of generic and biosimilar medicines in European countries. Pre-2021 Fair Pricing Forum webinar “Country experience and recommendations from the WHO Guideline on Country Pharmaceutical Pricing Policies”, 7. April 2021, Online

Vogler, Sabine (2021): European collaborations on patient access to medicines – Lessons learned and implications for national pricing policies such as external price referencing. HTA Conference, 23. März 2021, Online-Konferenz

Vogler, Sabine (2021): Preisbildung und Erstattung von Medikamenten in Österreich und international. Herausforderung hochpreisige Medikamente, internationale Diskussionen, Transparenz. imh-Konferenz "Praxiswissen", 19. Jänner 2021, online

Vogler, Sabine (2020): Medikamente zu „fairen“ Preisen: Aktuelle Herausforderungen, Diskussionen und Lösungsansätze in Europa. 8. AMNOG-Infotag, 11. November 2020, Online

Vogler, Sabine (2020): Affordability of medicines for patients and health systems sustainability. PGEU Economic Working Group, 8. September 2020, online

Vogler, Sabine; Haasis, Manuel Alexander; Van den Ham, Rianne; Suleman, Fatima (2020): Assessment of cross-country collaborations to improve access to medicines in the WHO European Region. Accepted Abstract. Euhea Conference 2020, 9. Juli 2020, Virtual conference

Vogler, Sabine; Zimmermann, Nina; Haasis, Manuel Alexander (2020): Comparison of co-payment regulations for medicines in 46 countries. Accepted Abstract. Euhea Conference 2020, 9. Juli 2020, Virtual conference

Fischer, Stefan; Vogler, Sabine (2020): Drug shortages: The situation in four European countries and their approaches to handle the problem. Accepted Abstract. Euhea Conference 2020, 9. Juli 2020, Virtual conference

Vogler, Sabine (2020): Maßnahmen europäischer Länder zum Umgang mit Lieferengpässen und zur Verbesserung der Versorgungssicherheit – Ergebnisse von GÖG-Studien. Virtuelle Pharma-Plattform, 17. September 2020, online

Vogler, Sabine (2020): Measures to manage, reduce and prevent medicines shortages in European countries in 2020. 16th World Congress on Public Health 2020, 15. Oktober 2020, online

Vogler, Sabine (2020): Pharmaceutical price comparisons. JoPPP (Journal of Pharmaceutical Policy and Practice) Conference 2020, 21. November 2020, online

Vogler, Sabine (2020): Strategies for containing costs of expensive new pharmaceuticals. Experience from European countries. 8th Meeting of the OECD Joint Network of Senior Budget and Health Officials, 11. Februar 2020, Paris

Vogler, Sabine (2020): Transparency in medicines prices and pharmaceutical policies - Components and examples. 16th World Congress on Public Health 2020, 13. Oktober 2020, online

Vogler, Sabine (2020): Wie mit Lieferengpässen umgehen? Ergebnisse aus einer Studie über die Maßnahmen in 24 Ländern. Versorgungssicherheit mit Arzneimitteln – eine gesamteuropäische Herausforderung, 26. November 2020, Online

Vogler, Sabine (2020): Zugang zu Medikamenten: Versorgungssicherheit und Leistbarkeit. Was tut sich auf europäischer und internationaler Ebene? imh PharmaKON Erstattung, 24. November 2020, online

Schneider, Peter; Rainer, Lukas; Zuba, Martin; Vogler, Sabine (2020): An analysis of price developments of biological medicines after patent expiration. Accepted Abstract. Euhea Conference 2020, 9. Juli 2020, Virtual conference

Vogler, Sabine (2019): What are the real impacts & benefits of cross-border collaborations? Findings from research. World Orphan Drug Congress Europe, 14. November 2019, Barcelona

Vogler, Sabine; Zimmermann, Nina; Haasis, Alexander; Babar-Ud-Din, Zaheer; Busse, Reinhard; Espin Balbino, Jaime (2019): Can pharmaceutical pricing and reimbursement policies make a difference in promoting equitable access to affordable medicines? From diagnosis to sustainable impact. Editorial. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien

Vogler, Sabine; Schneider, Peter (2019): Choosing the right medicines for price comparisons - Analysis of prices of pharmaceutical presentations of the same active ingredient. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien

Schneider, Peter; Zimmermann, Nina; Lepuschütz, Lena; Vogler, Sabine (2019): Estimating price developments of biological medicines during market exclusivity. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien

Vogler, Sabine; Schneider, Peter (2019): Impact of the external price referencing methodology (EPR) on medicine prices – Simulation of existing EPR models. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien

Vogler, Sabine; Van den Ham, Rianne; Haasis, Manuel Alexander; Suleman, Fatima (2019): Together working to improve access to medicines: analysis of cross-country collaborations in Europe. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 24. Oktober 2019, Wien

Vogler, Sabine; Pertile, Paolo; Gamba, Simona (2019): Impact of managed-entry agreements on medicines list prices. 4. International PPRI Conference 2019: Medicine access challenge - The value of pricing and reimbursement policies, 23. Oktober 2019, Wien

Vogler, Sabine (2019): Comparative analysis of pharmaceutical pricing and reimbursement policies in 47 countries. 24. Jahreskonferenz der Italian Health Economics Association (AIES), 3. Oktober 2019, Pisa

Vogler, Sabine (2019): How does real world evidence impact decision-making now and in the future: Using RWD/RWE to improve affordable access to medicines. Joint Meeting of the Health and Pharmaceutical Sector Chief Officers, 27. September 2019, Helsinki

Vogler, Sabine (2019): 10 Jahre Pharma-Plattform - Präsentation der Ergebnisse der Stakeholder-Befragung. Pharma-Plattform, 11. September 2019, Wien

Vogler, Sabine (2019): Managed Entry Agreements (MEA) and their confidentiality across Europe. Convegno Nazionale "Econonomia & Politica del Farmaco e delle Tecnologie Sanitarie", 28. Juni 2019, Mailand

Vogler, Sabine (2019): Improving access to HIV, Hep C and TB medicines - Which role do pricing policies play? AIDS Action Europe, 21. Juni 2019, Webinar

Vogler, Sabine (2019): Preisregulierung für neue Arzneimittel (mit Zusatznutzen) - Perspektiven und Lösungsansätze. Expertengespräch mit der AOK, 12. Juni 2019, Berlin

Vogler, Sabine (2019): Nutzenbewertung / Health Technology Assessment (HTA) von Arzneimitteln im Spannungsfeld zwischen Zulassung und Preisbildung - Europavergleich. Krankenhaus-Pharmazie Update, 24. Mai 2019, Wien

Vogler, Sabine (2019): Pharmaceutical Policies for Better Access to Medicines. WHO Barcelona Course on Health Financing for Universal Health Coverage, 19. März 2019, Barcelona

Vogler, Sabine (2019): Medicines shortages (non-accessibility of medicines) - from the perspective of pharmaceutical pricing and reimbursement policies. Treffen des COST ACTION CA15105 (European Medicines Shortages Research Network), 13. März 2019, Leuven

Vogler, Sabine (2019): Research study on impact and benefits of cross-country collaboration in the European region. 4. Konferenz der Austrian Health Economics Association (ATHEA), 1. März 2019, Wien

Vogler, Sabine (2019): Strategies for containing costs of expensive new pharmaceuticals - Experience from European countries. 8th Meeting of the OECD Joint Network of Senior Budget and Health Officials, 11. Februar 2019, Paris

Vogler, Sabine (2019): Zugang zu Medikamenten - Policy Briefs "How to stimulate innovation to meet patients' needs?" und "How to redesign pricing, reimbursement and procurement". Pharma Plattform, 31. Jänner 2019, Wien

Stürzlinger, Heidi; Röhrling, Isabella; Vogler, Sabine; Pilz, Eva; Eisenmann, Alexander (2018): Information Platform on Medication Safety within the Austrian Health Portal. Posterpräsentation. 6. Grazer Risikotag - Die Zukunft von Gestern im Gesundheitswesen, 5. April 2018, Graz

Vogler, Sabine (2018): Addressing high drug prices: What can be learned from European policies? Knowledge Network for Innovation and Access to Medicines. Graduate Institute of Geneva, 13. Dezember 2018, Webinar

Vogler, Sabine (2018): Biosimilars: Entwicklungen in Europa. Preisbildung und Erstattungssituation. imh Fachkonferenz Biosimilars, 31.Jänner 2018, Vienna

Vogler, Sabine (2018): Fair prices for medicines? Exploring competent authorities’ and Public Payers’ preferences on pharmaceutical policies. Annual Meeting & 100th Anniversary of the Austrian Economic Association (NOeG), 12. Mai 2018, Wien

Vogler, Sabine (2018): Financial burden of co-payment for outpatient medicines in European countries. EuHEA (European Health Association) Conference, 12. Juli 2018, Maastricht

Vogler, Sabine (2018): How to redesign pricing, reimbursement and procurement? Policy brief on ensuring access to medicines. Network of Competent Authority of Pricing and Reimbursement (NCAPR) meeting, 26. September 2018, Vienna

Vogler, Sabine (2018): Managing the Next Decade in Cancer. Innovation meets Growing Inequalities. World Health Summit 2018, 14. Oktober 2018, Berlin

Vogler, Sabine (2018): Medicines reimbursement policies in Europe. IADB (Inter-American Development Bank), 24. Oktober 2018, Webinar

Vogler, Sabine; Schneider, Peter (2018): Reimbursement for medicines - Similarities and differences of reference price systems in six European countries. EuHEA (European Health Association) Conference, 13. Dezember 2018, Maastricht

Vogler, Sabine; Suleman, Fatima (2018): Research study on impact and benefits of cross border collaboration in WHO European Region. INFARMED Conference “Facing the Challenges – Equity, Sustainability and Access, 29. November 2018, Lissabon

Vogler, Sabine (2018): Shining some light on confidential arrangements Relevance of discounts for pharmaceutical pricing in European countries. EbM-Kongress, 9. März 2018, Graz

Ostermann, Herwig; Bobek, Julia; Renner, Anna; Schneider, Peter; Vogler, Sabine (2016): A cost/benefit analysis of self-care initiatives in the European Union – Who’s better off, who’s worse off? EuHEA Conference 2016, 14. Juli 2016, Hamburg

Book

Vogler, Sabine; Haasis, Manuel Alexander; Dedet, Guillaume; Lam, Janice; Bak Pedersen, Hanne (2018): Medicines Reimbursement Policies in Europe. WHO Regional Office for Europe ISBN 9789289053365

Vogler, Sabine; Zimmermann, Nina; Habl, Claudia (2015): Kostenintensive Arzneispezialitäten im europäischen Preisvergleich. Gesundheit Österreich GmbH, Wien ISBN 978-3-85159-190-3

Vogler, Sabine; Leopold, Christine; Zimmermann, Nina (2011): Hospital Pharma. Arzneimittelmanagement in Krankenanstalten. Kurzbericht. Gesundheit Österreich GmbH, Vienna ISBN 13 978-3-85159-156-9

Leopold, Christine; Habl, Claudia; Vogler, Sabine; Morak, Simone (2008): PPRI-Pharma-Profil. Österreich 2008. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien ISBN 3-85159-121-6

Vogler, Sabine; Habl, Claudia; Leopold, Christine; Rosian-Schikuta, Ingrid; de Joncheere, Kees; Lyager Thomsen, Trine (2008): PPRI Report. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien ISBN 10 3-85159-104-6

Vogler, Sabine; Habl, Claudia (2003): Arzneimitteldistribution in Skandinavien. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien ISBN 3-85159-060-0

Vogler, Sabine; Freihoff, Wilhelm (2003): Kostenfaktoren der tierärztlichen Hausapotheke. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien ISBN 3-85159-059-7

Rosian-Schikuta, Ingrid; Antony, Katharina; Habl, Claudia; Vogler, Sabine; Weigl, Marion (2001): Benchmarking Arzneimittelausgaben. Strategien zur Kostendämpfung in der Europäischen Union. Gesundheit Österreich GmbH / Geschäftsbereich ÖBIG, Wien ISBN 3-85159-025-2

Other

Vogler, Sabine; Haasis, Manuel Alexander; Van den Ham, Rianne; Suleman, Fatima; Humbert, Tifenn; Garner, Sarah (2020): Cross-country collaborations to improve access to medicines and vaccines in the WHO European Region. World Health Organization, Denmark